Aquadex SmartFlow® System
Fluid overload in Heart Failure / Cardiorenal Syndrome (Adults)
Key Facts
About Nuwellis
Nuwellis, Inc. is a medical device company delivering innovative fluid-balance technologies to improve outcomes for patients with acute and chronic cardiorenal conditions. The company's clinically validated Aquadex system offers a safe, flexible, and efficient method for removing excess fluid, backed by over 20 years of clinical data and more than 65 studies. Nuwellis targets a significant market opportunity in heart failure, critical care, and pediatric nephrology, aiming to establish a new standard in fluid management.
View full company profileAbout Nuwellis
Nuwellis, Inc. is a medical device company delivering innovative fluid-balance technologies to improve outcomes for patients with acute and chronic cardiorenal conditions. The company's clinically validated Aquadex system offers a safe, flexible, and efficient method for removing excess fluid, backed by over 20 years of clinical data and more than 65 studies. Nuwellis targets a significant market opportunity in heart failure, critical care, and pediatric nephrology, aiming to establish a new standard in fluid management.
View full company profileAbout Nuwellis
Nuwellis, Inc. is a medical device company delivering innovative fluid-balance technologies to improve outcomes for patients with acute and chronic cardiorenal conditions. The company's clinically validated Aquadex system offers a safe, flexible, and efficient method for removing excess fluid, backed by over 20 years of clinical data and more than 65 studies. Nuwellis targets a significant market opportunity in heart failure, critical care, and pediatric nephrology, aiming to establish a new standard in fluid management.
View full company profileAbout Nuwellis
Nuwellis, Inc. is a medical device company delivering innovative fluid-balance technologies to improve outcomes for patients with acute and chronic cardiorenal conditions. The company's clinically validated Aquadex system offers a safe, flexible, and efficient method for removing excess fluid, backed by over 20 years of clinical data and more than 65 studies. Nuwellis targets a significant market opportunity in heart failure, critical care, and pediatric nephrology, aiming to establish a new standard in fluid management.
View full company profile